Moody's to review Valeant on Medicis deal; Novartis touts new Lucentis data;

 @FiercePharma: Good news for pharma's stop-smoking products: Quitters are more successful with patches, drugs, study finds. More | Follow @FiercePharma

> Valeant Pharmaceuticals ($VRX) nabbed a $2.75 billion bridge load for its Medicis Pharmaceutical buyout as Moody's said it would review the company for a downgrade. Report

> Novartis ($NVS) announced new data affirming the long-term safety and effectiveness of its eye treatment Lucentis. Report

> Mylan's ($MYL) Indian subsidiary was selected to supply HIV-fighting drugs to the country's National AIDS Control Organization. Report

> Suppliers will keep turning out substandard drug ingredients as long as drugmakers continue to buy them, the World Health Organization says. Report

> The U.K. has tapped a new health secretary, Jeremy Hunt, to replace Andrew Lansley, who backed a controversial overhaul of the government health service. Report

Biotech News

 @FierceBiotech: Can a triple-play COPD drug protect GSK from Novartis' QVA149? Story | Follow @FierceBiotech

 @JohnCFierce: Orexigen says it will complete Contrave study enrollment later this year, interim analysis in 2013. Release | Follow @JohnCFierce

> Novartis bets big that canakinumab can conquer a vast cardio market. Article

> Intercept Pharma files for $75M IPO to back PhIII liver drug. News

> Roche spotlights top blockbuster bets as it showcases R&D. Report

> Pfizer wins FDA approval for orphan chronic myelogenous leukemia drug. Story

Medical Device News

 @FierceMedDev: Slow growth ahead for the vascular access device market? Release | Follow @FierceMedDev

 @MarkHFierce: Shire has regulatory approval in Canada for its new diabetic foot ulcer treatment. Item | Follow @MarkHFierce

 @DamianFierce: Roche is betting big on companion diagnostics for its pipeline drugs. Article | Follow @DamianFierce

> Intact Vascular lands $15.5M to market PAD device. Story

> CircuLite's tiny blood pump locks down CE mark. News

Biomarkers News

> Mesothelioma markers predict response to Alimta. Story

> Lab aims to pinpoint PTSD with biomarkers. News

> Merck Serono launches biomarker spinoff. More

> Researchers find new brain cancer target. Article

> 'Traffic light test' could spot liver disease earlier. Item

Drug Delivery News

> Nanoparticles protect heart and cut cancer drug resistance. Article

> Cross-shaped RNA carries drugs to cells. More

> Pulmatrix is breathing relief into COPD. Story

> University snags $2.6M for HIV nanodrug delivery. News

And Finally... Mayo Clinic researchers have formulated an assessment to identify rheumatoid arthritis patients at highest risk of infection. Report